AIM (STOCKS)
AIM ImmunoTech Inc.
$0.541400
+0.017400 (+3.32%)
Prev close: $0.524000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas Kenwood Equels
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.40M
- Employees
- 23
- P/E (TTM)
- -0.04
- P/B (TTM)
- -0.16
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.44 | $-0.97 | -0.4663 | -47.89% |
|
Sep 2025 (Q3)
|
$-1.57 | $-0.98 | -0.5846 | -59.43% |
|
Jun 2025 (Q2)
|
$-3.68 | $-8.07 | +4.3956 | +54.46% |
|
Mar 2025 (Q1)
|
$-5.00 | $-8.07 | +3.0769 | +38.12% |
Financial Statements
| Assets | $22.11M |
| Current Assets | $14.44M |
| Inventory | $8.14M |
| Other Current Assets | $6.30M |
| Noncurrent Assets | $7.68M |
| Fixed Assets | $4.62M |
| Other Non-current Assets | $3.06M |
| Liabilities | $10.40M |
| Current Liabilities | $6.88M |
| Wages | $856.00K |
| Other Current Liabilities | $6.02M |
| Noncurrent Liabilities | $3.52M |
| Equity | $11.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.72M |
| Liabilities And Equity | $22.11M |